Harbour BioMed
HBM is a biopharmaceutical company that discovers and develops immuno-oncology therapeutics for the treatment of cancer and inflammatory diseases.
Business Model:
Revenue: $0
Employees: 51-200
Industries / Tags:
Detailed Harbour BioMed Information
Geographic Data
Address: No. 987 Cailun Road
City: Shanghai
State: shanghai municipality
Zip: 201203
Country: CN
Financial Info
Stage:
series c
Raised Last:
$103M
Raised Total:$313M
Social
Metrics
4,122,025Website Global Rank
2,802Website Monthly Traffic
Twitter Followers
Description
HBM is a biopharmaceutical company that discovers and develops immuno-oncology therapeutics for the treatment of cancer and inflammatory diseases.
Contact Phone:
Contact Email:
Harbour BioMed went public on 12/10/2020 on the Hong Kong Stock Exchange
Listed Exchange:
Hong Kong Stock Exchange
IPO Date:
12/10/2020
Ticker Symbol:
2142
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2023 | HBM Alpha Therapeutics | Seed Round | - |
| Announced Date | Name | Price |
|---|---|---|
| 12/2016 | Harbour Antibodies |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
